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Introduction
Intra-articular steroid (IAS) injections are a safe and effec-
tive therapy in the management of Juvenile Idiopathic
Arthritis (JIA). Timely access to joint injections, including
appropriate anaesthesia, is now considered standard of
care in the treatment of JIA. Despite this, little is known
about the resource burden created by IAS provision.
Published data is also lacking to inform families of the
likely role that IAS will play in the management of their
child’s disease.
Objectives
To describe the role of intra-articular steroid injections in
the management of a large cohort of patients with Juvenile
Idiopathic Arthritis at a tertiary paediatric Rheumatology
centre over a 5 year period, as well as the resource burden
this created.
Methods
All patients with Juvenile Idiopathic Arthritis who
attended the Royal Children’s Hospital, Melbourne, over a
5 year period between 1 January 2009 and 31 December
2013 were identified using our computerised database.
This is a comprehensive clinical tool coded in Microsoft
Access, which is used to record all Rheumatology patient
demographics, contacts, procedures, communications and
therapies. Data were extracted into an Excel spreadsheet
and analysed using descriptive statistics. For the purpose
of this study, multiple joint injections performed on the
same patient on the same day were considered to be a
single joint injection procedure.
Results
A total of 544 patients with JIA were cared for during the
study period, including 337 patients with a new diagnosis
of JIA. 338 (62.0%) of these patients were female. 410
patients (75.4%) underwent 892 joint injection procedures
during the study period. 419 of these procedures (47%)
were performed under general anaesthetic, with a median
patient age of 6.48 years (range 1.12-18.53). 473
procedures (53.0%) were performed under nitrous oxide
sedation, with a median patient age of 12.66 years (range
1.71-20.00). Of newly diagnosed patients who required
joint injection, median time to first IAS was 35 days
(range 0-1169). 87% of new patients who required joint
injections during follow up were injected within 6 months
of diagnosis. Throughout the study period, new JIA
diagnoses increased by 20.90%, joint injections procedures
increased by 7% and approvals for biologic agents
increased by 200%.
Conclusion
Intra-articular steroid injections are a core aspect of the
management of patients with JIA, with over 75% of
patients requiring injection over a five year period.
General anaesthetic was required in nearly half (47%) of
these procedures, and was most important in younger
patients. Of newly diagnosed patients who required IAS
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